论文信息 - Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19 - 字舞流文

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

N. Freemantle | A. Agyeman | N. Longley | J. Standing | D. Lowe | Li-An K Brown | Felicia Ikeji | Kashfia Chowdhury | Hakim-Moulay Dehbi | Á. Lennon | A. Checkley | J. Breuer | K. Chowdhury | S. Davey | P. Yee | F. Ikeji | A. Ndoutoumou | D. Shah | A. Rai | N. Freemantle | F. Investigators | D. Shah | H. Dehbi | Stephanie Davey | Amalia Ndoutoumou | Alexander Lennon | Abhulya Rai | Nicola Longley | A. Lennon